Year: 2020
Type: article
Abstract: In response to the novel COVID-19 global pandemic, there has been a mass mobilization of the scientific community to find a cure. Gao et al (Science, https://doi.org/10.1126/science.abc1932) have recently developed an inactivated SARS-CoV-2 virus candidate vaccine that induced production of neutralizing antibodies against multiple strains in rodents and non-human primates and protected macaque monkeys against infection without evidence of antibody-dependent immune enhancement. Parallel efforts are ongoing to repurpose existing drugs and develop novel therapeutic agents effective against COVID-19.
Authors: Marc E. Rothenberg, Jean Bousquet
Institution: Centre Hospitalier Universitaire de Montpellier
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,550
OpenAlex ID: W4205224537